Sidney Xi Liang

USPTO Granted Patents = 15 (Patent Applications = 2)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 46(Granted Patents)

Location History:

Hamden, CT (US) (2003 - 2004)
Fishers, IN (US) (1998 - 2006)
Bethany, CT (US) (2005 - 2020)

Company Filing History:

7 out of 4,446

Eli Lilly and Company

patents

5 out of 70

Bayer Pharmaceuticals Corporation

Years Active: 1998-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492204 - Substituted (7H-pyrrolo[2,3-D]pyrimidin-4-yl) amino compounds useful as JAK 1 inhibitors (2025-12-09),

2. 10703756 - Pyrrolo[2,3-D]pyrimidinyl, pyrrolo[2,3-B]pyrazinyl, pyrrolo[2,3-B]pyridinyl acrylamides and epoxides thereof (2020-07-07),

3. 8748459 - [object Object] (2014-06-10),

4. 7906653 - Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation (2011-03-15),

5. 7714004 - Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation (2010-05-11),

6. 7476742 - Indane acetic acid derivatives and their use as pharmaceutical agents (2009-01-13),

7. 7423050 - [object Object] (2008-09-09),

8. 7265144 - Anilinopyrazole derivatives useful for the treatment of diabetes (2007-09-04),

9. 7109196 - 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders (2006-09-19),

10. 7045545 - Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists (2006-05-16),

11. 6900205 - 1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders (2005-05-31),

12. 6828332 - Piperidine derivatives as reuptake inhibitors (2004-12-07),

13. 6664274 - Piperidine derivatives as serotonine reuptake inhibitors (2003-12-16),

14. 6436964 - Piperidine derivatives having effects on serotonin related systems (2002-08-20),

15. 5792763 - Serotonin 5-HT.sub.1F agonists (1998-08-11),

Title: Sidney Xi Liang: Innovator in Pharmaceutical Chemistry

Introduction

Sidney Xi Liang is a prominent inventor based in Bethany, CT (US), known for his significant contributions to pharmaceutical chemistry. With a total of 14 patents to his name, Liang has made remarkable advancements in the field, particularly in the development of compounds that target specific biological pathways.

Latest Patents

Liang's latest patents include innovative compounds such as pyrrolo[2,3-D]pyrimidinyl, pyrrolo[2,3-B]pyrazinyl, and pyrrolo[2,3-B]pyridinyl acrylamides and epoxides. These compounds are designed to be pharmaceutically active and are particularly useful for inhibiting Janus Kinase (JAK). Additionally, he has developed compounds that activate 5-HT receptors, which are beneficial for treating and preventing migraines in mammals. His inventions also encompass methods for synthesizing these compounds and their intermediates.

Career Highlights

Throughout his career, Sidney Xi Liang has worked with leading pharmaceutical companies, including Eli Lilly and Company and Bayer Pharmaceuticals Corporation. His work has significantly impacted the development of new therapeutic agents, showcasing his expertise in medicinal chemistry.

Collaborations

Liang has collaborated with notable colleagues in the field, including Yao-Chang Xu and Daniel Timothy Kohlman. These partnerships have fostered innovation and contributed to the advancement of pharmaceutical research.

Conclusion

Sidney Xi Liang's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of new treatments for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.